Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2026-03-26 @ 11:36 PM
Study NCT ID:
NCT00298766
Status:
COMPLETED
Last Update Posted:
2012-06-25
First Post:
2006-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
26866138-CAN-2007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |